Tenaya Therapeutics (TNYA) Prepaid Assets (2020 - 2026)
Tenaya Therapeutics' (TNYA) quarterly Prepaid Assets came in at $5.0 million in Q1 2026, down 20.21% year-on-year from $6.3 million in Q1 2025, and up 392.49% quarter-over-quarter from $1.0 million in Q4 2025.
Tenaya Therapeutics (TNYA) Prepaid Assets (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $5.0 million for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 20.21% year-over-year to $5.0 million in Q1 2026; TTM through Mar 2026 was $5.0 million, a 20.21% decrease from a year earlier, with the FY2025 full-year figure at $1.0 million, down 82.71% from the prior year.
- Prepaid Assets rose to $5.0 million in Q1 2026 per TNYA's latest filing, from $1.0 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $7.6 million in Q3 2022 and bottomed at $218000.0 in Q2 2025.
- The 5-year median for Prepaid Assets is $5.0 million (2026), against an average of $4.2 million.
- Across the five-year window, Prepaid Assets soared 639.87% in 2023 and tumbled 84.5% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $938000.0 in 2022, then surged by 639.87% to $6.9 million in 2023, then slipped by 14.57% to $5.9 million in 2024, then plunged by 82.71% to $1.0 million in 2025, then jumped by 392.49% to $5.0 million in 2026.
- Per Business Quant, the three latest TNYA Prepaid Assets figures stand at $5.0 million (Q1 2026), $1.0 million (Q4 2025), and $990000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tenaya Therapeutics | 167.00 Mn | 167.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.05 Mn |
| Dec 31, 2025 | 1.03 Mn |
| Sep 30, 2025 | 990,000.00 |
| Jun 30, 2025 | 218,000.00 |
| Mar 31, 2025 | 6.33 Mn |
| Dec 31, 2024 | 5.93 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.41 Mn |
| Mar 31, 2024 | 6.45 Mn |
| Dec 31, 2023 | 6.94 Mn |
| Sep 30, 2023 | 5.08 Mn |
| Jun 30, 2023 | 6.40 Mn |
| Mar 31, 2023 | 6.82 Mn |
| Dec 31, 2022 | 938,000.00 |
| Sep 30, 2022 | 7.62 Mn |
| Jun 30, 2022 | 4.78 Mn |
| Mar 31, 2022 | 3.33 Mn |
| Dec 31, 2021 | 4.06 Mn |
| Sep 30, 2021 | 4.36 Mn |
| Jun 30, 2021 | 1.34 Mn |